Canopy Growth Corporation develops and sells cannabis products for adult-use and medical markets, with common shares trading as CGC on Nasdaq and WEED on the TSX. Company updates frequently cover Canadian brand activity across Tweed, Deelish, 7ACRES, DOJA, Deep Space and related formats including flower, pre-rolls, vapes, softgels and minor cannabinoid products.
News also centers on medical cannabis services through Canada House Clinics and the Abba Medix online channel, Storz & Bickel vaporization devices, operating and financial results, capital-structure actions, shareholder voting matters and governance changes. Canopy Growth also discloses its unconsolidated, non-controlling interest in Canopy USA as exposure to the U.S. THC market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
On April 14, 2023, Canopy Growth (NASDAQ: CGC, TSX: WEED) announced an Exchange Agreement with Greenstar Canada Investment Limited Partnership, a subsidiary of Constellation Brands, to extinguish approximately C$100 million (around USD$73.9 million) in unsecured notes due 2023. The agreement involves a cash payment for accrued interest and a Promissory Note of C$100 million, due December 31, 2024, with an interest rate of 4.25%. Following this transaction, Canopy Growth plans to create a new class of Exchangeable Shares that will be convertible into common shares. This strategic move aims to preserve cash and reduce annual expenses as Canopy Growth looks to strengthen its financial position.